XNCR

Xencor is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases. The company uses its proprietary XmAb protein engineering technology platform to create next-generation antibody therapeutics with improved efficacy and safety profiles. Xencor has multiple product candidates in clinical development and partners with leading pharmaceutical companies.